Search research articles
Contact Us
Filters
Showing results (171-180 of 222) with videos related to
Page
of 23
Sort By:
British Journal of Cancer
|
December 16, 2010
Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study
S-Y Liao, W H Rodgers, J Kauderer, et al.
Frontiers in Oncology
|
November 12, 2016
NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer
Neil T Phippen, Nicholas W Bateman, Guisong Wang, et al.
Gynecologic Oncology
|
January 20, 2020
Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities
Nicole B Gaulin, Jamie L Lesnock, Chunqiao Tian, et al.
Gynecologic Oncology
|
October 21, 2009
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study
Gini F Fleming, Michael W Sill, Kathleen M Darcy, et al.
Gynecologic Oncology
|
September 20, 2021
Obesity and altered angiogenic-related gene expression in endometrial cancer
Lauren Patterson Cobb, Sharareh Siamakpour-Reihani, Dadong Zhang, et al.
International Journal of Cancer
|
September 11, 2014
Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis
Kate Lawrenson, Paulette Mhawech-Fauceglia, Jenny Worthington, et al.
European Journal of Cell Biology
|
September 3, 1999
Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cells
K M Darcy, A L Wohlhueter, D Zangani, et al.
Gynecologic Oncology
|
February 27, 2013
A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study
Kimberly K Leslie, Michael W Sill, Edgar Fischer, et al.
Gynecologic Oncology
|
February 8, 2020
Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival
Christine Rojas, Chunqiao Tian, Matthew A Powell, et al.
Gynecologic Oncology
|
August 24, 2020
Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit
Michael T Richardson, David P Mysona, David A Klein, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 222) with videos related to
Sort By:
Page
of 23
British Journal of Cancer
|
December 16, 2010
Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study
S-Y Liao, W H Rodgers, J Kauderer, et al.
Frontiers in Oncology
|
November 12, 2016
NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer
Neil T Phippen, Nicholas W Bateman, Guisong Wang, et al.
Gynecologic Oncology
|
January 20, 2020
Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities
Nicole B Gaulin, Jamie L Lesnock, Chunqiao Tian, et al.
Gynecologic Oncology
|
October 21, 2009
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study
Gini F Fleming, Michael W Sill, Kathleen M Darcy, et al.
Gynecologic Oncology
|
September 20, 2021
Obesity and altered angiogenic-related gene expression in endometrial cancer
Lauren Patterson Cobb, Sharareh Siamakpour-Reihani, Dadong Zhang, et al.
International Journal of Cancer
|
September 11, 2014
Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis
Kate Lawrenson, Paulette Mhawech-Fauceglia, Jenny Worthington, et al.
European Journal of Cell Biology
|
September 3, 1999
Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cells
K M Darcy, A L Wohlhueter, D Zangani, et al.
Gynecologic Oncology
|
February 27, 2013
A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study
Kimberly K Leslie, Michael W Sill, Edgar Fischer, et al.
Gynecologic Oncology
|
February 8, 2020
Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival
Christine Rojas, Chunqiao Tian, Matthew A Powell, et al.
Gynecologic Oncology
|
August 24, 2020
Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit
Michael T Richardson, David P Mysona, David A Klein, et al.
Page
of 23